Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
SB

SHAWN BISHOP

Registered · LDAActive

At a glance

Works on
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career
WASHINGTON, DC · current
Government experience
Chief Health Advisor
US Sen. Finance Comm. (2/16/21-11/15/2024); Senior Advisor, US Sen. Finance Comm. (5/6/19 - 10/1/19); Professional Staff, US Sen. Finance Comm. (2/5/2005-10/1/2010).
Covered official positions, as disclosed on federal filings

The past 12 months

Clients
3
past 12 months
Filings
4
past 12 months
Agencies contacted
Centers For Medicare and Medicaid Services (CMS)HOUSE OF REPRESENTATIVESSENATEExecutive Office of the President (EOP)Health Resources & Services Administration (HRSA)

Specific issues

Issues related to organ transplantation and the organ transplantation system.
Medical/Disease Research/Clinical Labs · 2026 Q1
Issues related to GLP-1 products, including coverage for GLP-1 products and related health services; Issues related to expanded GLP-1 coverage, including Medicare and Medicaid coverage for GLP-1 products and related health services within CMMI models to achieve healthy outcomes for patients; Issues related to TrumpRx.
Health Issues · 2026 Q1
Issues related to expanded GLP-1 coverage, including Medicare and Medicaid coverage for GLP-1 products and related health and support services within CMMI models to achieve healthy outcomes for patients; Issues related to TrumpRx.
Medicare/Medicaid · 2026 Q1
Issues related to federal coverage of contraception; Issues related to prescription drug pricing and distribution platforms.
Health Issues · 2026 Q1
Issues related to updates to the National Organ Transplant Act (NOTA) of 1984 (P.L. 98-507).
Medical/Disease Research/Clinical Labs · 2026 Q1
Issues related to biotechnology policy.
Health Issues · 2025 Q1

Clients

2026 · 2 filings
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
Past clients2
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings4
2026 Q1
MAYNE PHARMA (USA), INC.
Q1lda.gov →
2026 Q1
TRANSMEDICS GROUP, INC.
Q1lda.gov →
2026 Q1
WW INTERNATIONAL, INC.
Q1lda.gov →
2026 Q1
TRANSMEDICS GROUP, INC.
RRlda.gov →
Older filings2
2025 Q1
CELLDEX THERAPEUTICS, INC.
RRlda.gov →
2024 Q4
ALLIANCE FOR AGING RESEARCH
Q4lda.gov →